vendredi 23 septembre 2016
Suboxone maker sued by U.S. states alleging anticompetitive practices
35 U.S. states and District of Columbia file an antitrust lawsuit alleging that British drugmaker Indivior tried to keep cheaper, generic versions of Suboxone off the market.
Related Posts:
'There was a screw-up': UBC researchers pull paper linking vaccine component to autism Researchers from the University of British Columbia are retracting their scientific paper linking aluminum in vaccines to autism in mice, because one of the co-authors claims figures published in the study were deliberately … Read More
Second Opinion | Remembering forgetting could be a good sign New research suggests that people with mild cognitive decline who are aware of their memory loss might have a lower risk of developing dementia than people who don't notice they're forgetting things. … Read More
Cannabis research booms with backing of commercial growers The budding marijuana industry is spurring new research around cannabis that will have long-term effects on a variety of fields, from farming to new medicine, as companies look for solid scientific data on the substance. … Read More
Marijuana is not an all-purpose medical cure As a medical doctor, my concern is that as marijuana becomes more easily available, Canadians may become more inclined to self-medicate with this so-called "miracle drug." … Read More
Healing invisible wounds with the Art Cart The Gifts of Light non-profit group in Toronto supplies patients at the Centre for Addiction and Mental Health with free hygiene products, clothing - and now art classes. … Read More
0 comments:
Enregistrer un commentaire